Table 3.
Comparison of quantitative MRI features of benign versus contralateral normal axillary lymph nodes (ALNs) in 34 patients with breast cancer.
| Benign ALN Mean (SD) |
Normal ALN Mean (SD) |
p-value | |
|---|---|---|---|
| Kinetic features | |||
| Peak enhancement % | 398.7 (225.9) | 411.7 (470.7) | 0.38 |
| Washout % | 88.4 (12.8) | 82.8 (16.8) | 0.4 |
| Size | |||
| Angiographic volume (mm3) | 3.2 (4.5) | 0.5 (0.6) | 0.001* |
| Manual volume (mm3) | 3.5 (5.9) | 0.8 (0.7) | 0.0002* |
| Maximum size (mm) | 20.7 (9.9) | 14.9 (6.3) | 0.06 |
| Minimum size (mm) | 12.5 (5.3) | 6.8 (2.8) | <0.0001* |
| DW MRI features | |||
| Mean ADC (mm2/s) | 1.03 (0.2) | 1.12 (0.2) | 0.08 |
| Minimum ADC (mm2/s) | 0.44 (0.2) | 0.69 (0.3) | 0.003* |
p-values calculated by Wilcoxon signed-rank test
Abbreviations: DW = diffusion weighted, ALN = axillary lymph node, ADC = apparent diffusion coefficient
denotes statistically significant difference